![[RECENTLY UPDATED] Global Database of Exosome Companies, 2026](https://bioinformant.com/wp-content/uploads/2026/02/Exosome-Companies-Square.jpg)
Description
The world’s only database of companies that specialize in developing exosome therapies, diagnostics, research products, and platform technologies.
This week only, you can claim this database for an unusual $150 off. Act fast because this offer expires Friday, April 3rd, at midnight.
Exosomes are small vesicles ranging from 30-100nm in size that are found in nearly all eukaryotic fluids and facilitate a range of important cellular functions. They transfer DNA, RNA, and proteins to other cells, thereby altering the function of the targeted cells.
In recent years, exosomes have been gaining momentum as a strategy for accessing the therapeutic effects of cells without the risks and difficulties of administering cells to patients. With at least 41,103 scientific articles published about exosomes and at least 516 clinical trials, these small vesicles have intriguing potential to be used across a range of therapeutic applications.
Global Database of Exosome Companies
The database features all known companies worldwide who specialize in developing exosome and extracellular vesicle (EV) therapies, diagnostics, research products, and platform technologies.
It takes our team of analysts hours of exhaustive research to uncover these exosome companies from across the globe, but thankfully, we have a talented and multilingual team who is up to the task.
We also continually crowdsource feedback from our audience of nearly one million readers per year, as well as nearly one hundred thousand followers across our social media platforms.
The database features the following information:
-
Company Name
- Company Website
- Headquarters (City / State)
- Headquarters (Country)
- Description of Exosome Technology
-
LinkedIn Page
- Phone Description
Use this list of exosome companies to:
- Identify global competitors within the exosome marketplace
- Learn about technologies being developed by exosome market leaders
- Identify regions that are “hotspots” for exosome therapies
- Identify M&A activity within the exosome industry
Proprietary Insights Based on 20+ Years of Tracking
It takes our analysts a great deal of research to uncover these exosome companies from across the globe. In addition to diligently searching through hundreds of resources, we utilized translators and crowd-sourced feedback from BioInformant’s partners, clients, and readership. As you can imagine, the quality of this database would not be possible without the past 20 years of following this industry and developing proprietary datasets (to which AI crawlers do not have access).
Best of all, you don’t have to worry about AI errors or inaccuracies, which are common within our rapidly moving field.
If you want immediate and actionable insights from a trusted, U.S. based provider that specializes exclusively in cell therapy market insights, then this database is for you.
Database of Exosome Companies
Because this database is an essential resource within our company, we are confident it will be a valuable resource for you too. It was originally developed in-house for our own purposes, but we have had many clients requesting access to it.
When you check out below, your product will be delivered instantly as an Excel download.
Of course, your investment is backed by our Money Back Guarantee.
Format: Excel File (Delivered Instantly with Purchase)
No. of Companies: 146 Total
Last Updated: April 1, 2026
This week only, you can claim this database for an unusual $150 off. Remember to act fast, because this offer expires this Friday, April 3rd, at midnight!
*Note: Understandably, not all of the companies included in this database could be fit into its product graphic, so your company is likely included even if it is not shown in the feature image above.
